Rapid Action of Retinoic Acid on the Hypothalamic Pituitary Adrenal Axis

Peter I Imoesi, Ellen E Bowman, Patrick Niall Stoney, Sylwia Matz, Peter McCaffery* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)
2 Downloads (Pure)

Abstract

Retinoic acid is the active metabolite of vitamin A but is also used as a medication, primarily for acne in which the treatment regime lasts several months. A number of studies have indicated that treatment with retinoic acid over this time period impacts the hypothalamic-pituitary-adrenal (HPA) axis and may contribute to a number of the side-effects of the drug. No studies though have investigated the short-term, early effects retinoic acid may have on the HPA axis via the transcriptional pathways activated by the retinoic acid receptor. This study investigated the action of retinoic acid over 3 days on regulatory components of the HPA axis. Several key genes involved in glucocorticoid feedback pathways in the hippocampus, hypothalamus and pituitary were unchanged after 3-days exposure to retinoic acid. Key elements though in the adrenal gland involved in corticosterone and aldosterone synthesis were altered in particular with the Cyp11b2 gene downregulated in-vivo and ex-vivo. The rapid, 5 hours, change in Cyp11b2 expression suggested this activation may be direct. These results highlight the adrenal gland as a target of short-term action of retinoic acid and potentially a trigger component in the mechanisms by which the long-term adverse effects of retinoic acid treatment occur.

Original languageEnglish
Article number259
Number of pages8
JournalFrontiers in Neuroscience
Volume12
DOIs
Publication statusPublished - 30 Oct 2019

Fingerprint

Tretinoin
Adrenal Glands
Retinoic Acid Receptors
Acne Vulgaris
Corticosterone
Drug-Related Side Effects and Adverse Reactions
Aldosterone
Vitamin A
Glucocorticoids
Genes
Hypothalamus
Hippocampus
Down-Regulation

Keywords

  • retinoic acid
  • Hypothalamic pituitary adrenal (HPA) axis
  • Corticosterone
  • adrenal gland
  • Aldosterone synthesis
  • CYP11B1
  • CYP11B2
  • Chronic traumatic encephalopathy
  • TDP-43
  • Amyotrophic lateral sclerosis
  • Microtubule associated tau protein
  • Frontotemporal dementia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rapid Action of Retinoic Acid on the Hypothalamic Pituitary Adrenal Axis. / Imoesi, Peter I; Bowman, Ellen E; Stoney, Patrick Niall; Matz, Sylwia; McCaffery, Peter (Corresponding Author).

In: Frontiers in Neuroscience, Vol. 12, 259, 30.10.2019.

Research output: Contribution to journalArticle

@article{54c48362770c4f56a1c8788ac898ba35,
title = "Rapid Action of Retinoic Acid on the Hypothalamic Pituitary Adrenal Axis",
abstract = "Retinoic acid is the active metabolite of vitamin A but is also used as a medication, primarily for acne in which the treatment regime lasts several months. A number of studies have indicated that treatment with retinoic acid over this time period impacts the hypothalamic-pituitary-adrenal (HPA) axis and may contribute to a number of the side-effects of the drug. No studies though have investigated the short-term, early effects retinoic acid may have on the HPA axis via the transcriptional pathways activated by the retinoic acid receptor. This study investigated the action of retinoic acid over 3 days on regulatory components of the HPA axis. Several key genes involved in glucocorticoid feedback pathways in the hippocampus, hypothalamus and pituitary were unchanged after 3-days exposure to retinoic acid. Key elements though in the adrenal gland involved in corticosterone and aldosterone synthesis were altered in particular with the Cyp11b2 gene downregulated in-vivo and ex-vivo. The rapid, 5 hours, change in Cyp11b2 expression suggested this activation may be direct. These results highlight the adrenal gland as a target of short-term action of retinoic acid and potentially a trigger component in the mechanisms by which the long-term adverse effects of retinoic acid treatment occur.",
keywords = "retinoic acid, Hypothalamic pituitary adrenal (HPA) axis, Corticosterone, adrenal gland, Aldosterone synthesis, CYP11B1, CYP11B2, Chronic traumatic encephalopathy, TDP-43, Amyotrophic lateral sclerosis, Microtubule associated tau protein, Frontotemporal dementia",
author = "Imoesi, {Peter I} and Bowman, {Ellen E} and Stoney, {Patrick Niall} and Sylwia Matz and Peter McCaffery",
note = "FUNDING PS was funded by a British Society for Neuroendocrinology (BSN) Project Support Grant. EB was funded by a BSN undergraduate student laboratory experience grant. The support also came from Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/P004806/1.",
year = "2019",
month = "10",
day = "30",
doi = "10.3389/fnmol.2019.00259",
language = "English",
volume = "12",
journal = "Frontiers in Neuroscience",
issn = "1662-4548",
publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Rapid Action of Retinoic Acid on the Hypothalamic Pituitary Adrenal Axis

AU - Imoesi, Peter I

AU - Bowman, Ellen E

AU - Stoney, Patrick Niall

AU - Matz, Sylwia

AU - McCaffery, Peter

N1 - FUNDING PS was funded by a British Society for Neuroendocrinology (BSN) Project Support Grant. EB was funded by a BSN undergraduate student laboratory experience grant. The support also came from Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/P004806/1.

PY - 2019/10/30

Y1 - 2019/10/30

N2 - Retinoic acid is the active metabolite of vitamin A but is also used as a medication, primarily for acne in which the treatment regime lasts several months. A number of studies have indicated that treatment with retinoic acid over this time period impacts the hypothalamic-pituitary-adrenal (HPA) axis and may contribute to a number of the side-effects of the drug. No studies though have investigated the short-term, early effects retinoic acid may have on the HPA axis via the transcriptional pathways activated by the retinoic acid receptor. This study investigated the action of retinoic acid over 3 days on regulatory components of the HPA axis. Several key genes involved in glucocorticoid feedback pathways in the hippocampus, hypothalamus and pituitary were unchanged after 3-days exposure to retinoic acid. Key elements though in the adrenal gland involved in corticosterone and aldosterone synthesis were altered in particular with the Cyp11b2 gene downregulated in-vivo and ex-vivo. The rapid, 5 hours, change in Cyp11b2 expression suggested this activation may be direct. These results highlight the adrenal gland as a target of short-term action of retinoic acid and potentially a trigger component in the mechanisms by which the long-term adverse effects of retinoic acid treatment occur.

AB - Retinoic acid is the active metabolite of vitamin A but is also used as a medication, primarily for acne in which the treatment regime lasts several months. A number of studies have indicated that treatment with retinoic acid over this time period impacts the hypothalamic-pituitary-adrenal (HPA) axis and may contribute to a number of the side-effects of the drug. No studies though have investigated the short-term, early effects retinoic acid may have on the HPA axis via the transcriptional pathways activated by the retinoic acid receptor. This study investigated the action of retinoic acid over 3 days on regulatory components of the HPA axis. Several key genes involved in glucocorticoid feedback pathways in the hippocampus, hypothalamus and pituitary were unchanged after 3-days exposure to retinoic acid. Key elements though in the adrenal gland involved in corticosterone and aldosterone synthesis were altered in particular with the Cyp11b2 gene downregulated in-vivo and ex-vivo. The rapid, 5 hours, change in Cyp11b2 expression suggested this activation may be direct. These results highlight the adrenal gland as a target of short-term action of retinoic acid and potentially a trigger component in the mechanisms by which the long-term adverse effects of retinoic acid treatment occur.

KW - retinoic acid

KW - Hypothalamic pituitary adrenal (HPA) axis

KW - Corticosterone

KW - adrenal gland

KW - Aldosterone synthesis

KW - CYP11B1

KW - CYP11B2

KW - Chronic traumatic encephalopathy

KW - TDP-43

KW - Amyotrophic lateral sclerosis

KW - Microtubule associated tau protein

KW - Frontotemporal dementia

UR - http://www.scopus.com/inward/record.url?scp=85046095805&partnerID=8YFLogxK

U2 - 10.3389/fnmol.2019.00259

DO - 10.3389/fnmol.2019.00259

M3 - Article

C2 - 31736706

VL - 12

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

SN - 1662-4548

M1 - 259

ER -